Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders.
about
Meta-analysis of the efficacy and safety of adding an angiotensin receptor blocker (ARB) to a calcium channel blocker (CCB) following ineffective CCB monotherapy.Renoprotective effects of renin-angiotensin system inhibitor combined with calcium channel blocker or diuretic in hypertensive patients: A PRISMA-compliant meta-analysis.
P2860
Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Azelnidipine and glucose toler ...... ents with metabolic disorders.
@en
type
label
Azelnidipine and glucose toler ...... ents with metabolic disorders.
@en
prefLabel
Azelnidipine and glucose toler ...... ents with metabolic disorders.
@en
P2093
P2860
P1476
Azelnidipine and glucose toler ...... ents with metabolic disorders.
@en
P2093
Hiroyuki Daida
Katsumi Miyauchi
Kazunori Shimada
P2860
P356
10.1586/14779072.2015.986464
P577
2014-12-01T00:00:00Z